The CCK-8 assay indicated that DUSP3-mediated stemness regulated the sensitivity of osteosarcoma cells to cisplatin (Figure 4K-N), suggesting that DUSP3 negatively regulates osteosarcoma cells stemness, thus improving their sensitivity to cisplatin. This evidence concerns the gene DUSP3 and osteosarcoma.